Core Scientific, Inc Tranche 2 Warrants
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $78,628 | $79,525 | $94,925 | $95,354 |
Gross Profit | 5,025 | 8,213 | 4,763 | -156 |
EBITDA | -26,284 | -42,596 | -234,875 | -419,362 |
EBIT | -47,768 | -65,003 | -264,030 | -448,053 |
Net Income | -936,799 | 580,693 | -265,541 | -455,259 |
Net Change In Cash | 78,628 | 79,525 | 94,925 | 95,354 |
Free Cash Flow | -87,279 | -129,021 | -15,184 | -25,461 |
Cash | 581,345 | 697,942 | 836,197 | 253,019 |
Basic Shares | 317,985 | 363,314 | 306,146 | 292,486 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $510,672 | $502,400 | $640,313 | $544,483 |
Gross Profit | 121,070 | 123,459 | 8,400 | 238,862 |
EBITDA | -1,156,955 | -63,121 | 167,610 | |
EBIT | -1,277,076 | -159,566 | 134,248 | |
Net Income | -1,315,005 | -246,487 | -2,146,318 | 47,312 |
Net Change In Cash | 510,672 | 502,400 | 640,313 | 544,483 |
Free Cash Flow | -52,065 | 48,953 | -396,470 | -116,010 |
Cash | 836,197 | 50,409 | 15,884 | 131,678 |
Basic Shares | 255,832 | 379,863 | 375,225 | 233,305 |
